Suppression of autoimmune diabetes by soluble galectin-1 - Wikidata - wikimedia - TriplyDB

Suppression of autoimmune diabetes by soluble galectin-1

Suppression of autoimmune diabetes by soluble galectin-1

http://www.wikidata.org/entity/Q34087128

about

The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer Progression Galectin-1 research in T cell immunity: past, present and future Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation.An update on the use of NOD mice to study autoimmune (Type 1) diabetes.Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes.Testing agents for prevention or reversal of type 1 diabetes in rodents.Ganglioside GM1 deficiency in effector T cells from NOD mice induces resistance to regulatory T-cell suppression Galectins in hematological malignancies.Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions Interaction of dendritic cells and T lymphocytes for the therapeutic effect of Dangguiliuhuang decoction to autoimmune diabetes.The regulatory power of glycans and their binding partners in immunity Galectin-1-mediated suppression of Pseudomonas aeruginosa-induced corneal immunopathology.Engineering galectin-glycan interactions for immunotherapy and immunomodulation Immunotherapy with regulatory T cells in transplantation.Galectin-1 and immunotherapy for brain cancer.Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus.Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target.'Sweetening' pregnancy: galectins at the fetomaternal interface.Possible novel biomarkers of organ involvement in systemic lupus erythematosus.Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function Tissue- and cell-specific localization of galectins, β-galactose-binding animal lectins, and their potential functions in health and disease.Inhibitory effects of the transcription factor Ets-1 on the expression of type I collagen in TGF-β1-stimulated renal epithelial cells.Regulation of Eosinophil Recruitment and Activation by Galectins in Allergic Asthma.Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy.Dual roles of endogenous and exogenous galectin-1 in the control of testicular immunopathology.Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression.Galectin-1 Impairs the Generation of Anti-Parasitic Th1 Cell Responses in the Liver during Experimental Visceral Leishmaniasis.Targeted inhibition of galectin 1 by thiodigalactoside dramatically reduces body weight gain in diet-induced obese rats.Galectin-1 promotes human neutrophil migration.Galectin-1: A Jack-of-All-Trades in the Resolution of Acute and Chronic Inflammation.Galectins in Intestinal Inflammation: Galectin-1 Expression Delineates Response to Treatment in Celiac Disease Patients.Reduced expression of galectin-1 and galectin-9 by leucocytes in asthma patients.Galectin-1 prolongs survival of mouse liver allografts from Flt3L-pretreated donors.Interactions Between the Neuroendocrine System and T Lymphocytes in Diabetes.The Role of Galectins as Modulators of Metabolism and Inflammation.

P2860

Q26750877-9A747BEE-8A2B-423D-8E89-0E87900A1DAA Q26825120-20EE9528-6EF4-4F2C-8A3B-3116FC6B2243 Q27336019-767F67C9-67C0-4DF3-92AC-6C764AD4C03E Q34192497-C6E114E5-2BC8-4D6A-84ED-BEAAC3F480B6 Q34508281-D83DCE00-7DE8-4A6E-89BC-1425F58D6C07 Q34660346-4AF52DEB-6B79-472B-A628-8456D11998FB Q34983677-5A58A8B2-9A72-4B91-AB13-A81657D63089 Q35180105-570E2B58-B637-43B6-A424-CA5C2E928066 Q35824985-31D45E8C-E51B-4544-9441-083594B6669F Q35917620-C59A40A8-09E5-4B17-BB77-CDBF5F58D415 Q36049534-2EF3B266-4C51-42B5-97C4-0AE1CB0AA58C Q36906422-0F70588F-DDD7-4E24-8A9A-E6A12D4CABB8 Q36946903-809E39FB-571B-4440-B73F-241665EAAEBC Q37107168-EE8E0FE5-3119-4725-AD86-7FA4CD30251C Q37773304-1FBB795C-CCCE-483D-B629-8FFE74B81991 Q37862237-E916B98E-B7A1-4ED9-A677-E3CEA4EAA9D0 Q38071420-F7FC74D4-5045-4BEA-913A-93D973738A7E Q38071660-52606E2D-F4B8-4FA2-9EEF-EB6C1F423F08 Q38081185-0DD70511-4711-4F6E-B4A3-66B5EB8E5ACB Q38193734-45380BDB-B89E-482C-9FA2-0429D5971795 Q38317758-A031E9CC-A9BC-4809-84CF-39ED9DB2B530 Q38945365-29E8E3EE-0A2A-4965-8654-DC29547C41EE Q39308744-14E54B23-E4F0-4908-8763-53E25163B76A Q39377433-6F506C67-B62B-4C45-868C-67C623428266 Q40170463-78A7E9D0-DE9F-406E-953D-87A42BE13826 Q42407157-193F0F9B-C9E8-4B2C-BB04-70DDF3B02142 Q42568683-F53CB5D3-6CF4-4F09-B480-38376BA89D07 Q42694566-1990C714-2CC4-4737-8208-BD2B035989B8 Q42827891-CA802AA4-464A-43E3-BE39-55379188198E Q44843923-D55264DD-753E-4335-BFFA-364BE531714A Q47381420-5BB2D6E3-8A14-4752-9B4B-8E188EFD14C1 Q52353649-E5DA681E-29D5-42BC-899F-B690E1E66C09 Q54285103-F21DE2F8-70AD-4416-A3C0-CC7D9B1E67F0 Q54453651-717ECA60-26E7-46DB-BA08-42D698EDE095 Q55337327-ACEE992A-EA58-4A34-9177-86D72FBC61AC Q55349770-216EABAB-F63E-47FF-B09B-F9D3C82BF2D7

P2860

Suppression of autoimmune diabetes by soluble galectin-1

http://www.wikidata.org/entity/Q34087128

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Suppression of autoimmune diabetes by soluble galectin-1

@ast

Suppression of autoimmune diabetes by soluble galectin-1

@en

Suppression of autoimmune diabetes by soluble galectin-1

@nl

type

label

Suppression of autoimmune diabetes by soluble galectin-1

@ast

Suppression of autoimmune diabetes by soluble galectin-1

@en

Suppression of autoimmune diabetes by soluble galectin-1

@nl

prefLabel

Suppression of autoimmune diabetes by soluble galectin-1

@ast

Suppression of autoimmune diabetes by soluble galectin-1

@en

Suppression of autoimmune diabetes by soluble galectin-1

@nl

P1433

Q34087128-9E14B861-164D-45DB-8A45-F46275A02332

P1476

Q34087128-5ED198B7-3F2B-4ED5-B7B3-DBB16A39953C

P2093

Q34087128-1793F9C4-0773-475B-9534-E81FEA576EB7

Q34087128-2BB89BA1-A47E-448E-8FF3-A055E115DE74

Q34087128-424C5476-8774-4EAC-9DD6-84D820904099

Q34087128-49E007D4-92D8-487B-983D-EBA718F0FD45

Q34087128-5CF5190D-7260-46CC-A55A-46D60D43BA8D

Q34087128-6741724E-8DD0-42C7-A4F7-146CFA1F541A

Q34087128-919AB6C7-558E-452C-B47A-8DC005378FF2

Q34087128-B5772375-3E81-4496-B30D-B7D734B8F790

Q34087128-BA2AA388-C52B-450E-BB27-1B22A018A423

Q34087128-C7F2352A-9F69-4588-91EA-1D73433E8E6F

P2860

Q34087128-00CC6486-3FCE-44E6-B215-3BC2DD2EBC4B

Q34087128-05DD772E-D0F5-447F-86D2-D6C86519C049

Q34087128-07090E7F-DFD2-4BCB-A3E6-F9B526975F48

Q34087128-12320C0D-1CF1-4CDF-A377-8E5BA0FEACFB

Q34087128-12FC1C87-4ECD-4221-B727-CD3E377AC7E9

Q34087128-1679DAC4-3B5F-4F05-A41F-E55A1DD8375C

Q34087128-1E36CD42-9AF1-4689-9081-FD0B52908DEB

Q34087128-1EBC7BBE-9C04-4E7F-B243-5155C32BA58F

Q34087128-2B6479D1-204D-4034-AE44-F467E4BB9BFC

Q34087128-2C05F548-18DF-4229-BA0E-B7D84A8C630D

P304

Q34087128-7A19A54F-3BA7-4668-A538-FC8F7EB54F3F

P31

Q34087128-672F59DE-1BBF-46B7-898F-A634EA8492B2

P356

Q34087128-D6A7D3DD-DD9E-478A-ACFF-CF6D3402EA44

P407

Q34087128-7E11F4D6-2EDC-483A-820E-0E57558A56E7

P433

Q34087128-BE7AA9CD-E04A-42D7-BFE3-93E034B7085B

P478

Q34087128-5FD61568-CC14-4170-BB45-83FE63426CF9

P50

Q34087128-FE162D45-AE30-43B8-9E1D-CF325A72B3F8

P577

Q34087128-4F6ECE77-82BD-444C-8784-6F70879AF34A

P5875

Q34087128-8D91FD50-771F-4EEE-97F7-AFB99879E97A

P698

Q34087128-F873182E-E020-47D8-BFBF-46956D9FED8B

P932

Q34087128-5700959F-354C-4F89-BEC2-D31A0A1B533B

P356

JIMMUNOL.0800839

P1433

Journal of Immunology

P1476

Suppression of autoimmune diabetes by soluble galectin-1

@en

P2093

Adrian E Morelli

http://www.w3.org/2001/XMLSchema#string

Adriana T Larregina

http://www.w3.org/2001/XMLSchema#string

Alicia R Mathers

http://www.w3.org/2001/XMLSchema#string

Angela Montecalvo

http://www.w3.org/2001/XMLSchema#string

Kai W Wucherpfennig

http://www.w3.org/2001/XMLSchema#string

Linda G Baum

http://www.w3.org/2001/XMLSchema#string

Mabel Pang

http://www.w3.org/2001/XMLSchema#string

Marcelo J Perone

http://www.w3.org/2001/XMLSchema#string

Massimo Trucco

http://www.w3.org/2001/XMLSchema#string

Nilufer Seth

http://www.w3.org/2001/XMLSchema#string

P2860

Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

Galectins: a new family of regulators of inflammation.

Immunology of type 1 diabetes. Intervention and prevention strategies.

Corpse clearance defines the meaning of cell death.

In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice.

Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?

Overview of prevention and intervention trials for type 1 diabetes.

Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells

A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation.

P304

2641-2653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0800839

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P50

Suzanne Bertera

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24031963

http://www.w3.org/2001/XMLSchema#string

P698

19234158

http://www.w3.org/2001/XMLSchema#string

P932

2929001

http://www.w3.org/2001/XMLSchema#string